WallStreetZenWallStreetZen

NYSE: DGX
Quest Diagnostics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DGX past earnings growth

How has DGX's earnings growth performed historically?
Company
-38.77%
Industry
2.54%
Market
36.76%
DGX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DGX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DGX's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DGX past revenue growth

How has DGX's revenue growth performed historically?
Company
-6.81%
Industry
13.01%
Market
163.96%
DGX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DGX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DGX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DGX earnings and revenue history

Current Revenue
$10.3B
Current Earnings
$1.2B
Current Profit Margin
12%
DGX's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

DGX Return on Equity

Current Company
19.4%
Current Industry
78%
Current Market
-8.3%
DGX's Return on Equity (19.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DGX announces earnings.

DGX Return on Assets

Current Company
9.2%
Current Industry
6.3%
DGX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DGX Return on Capital Employed

Current Company
15.14%
Current Industry
10.8%
DGX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DGX vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DGX$10.29B$2.19B$1.24B+7.72%+16.27%
PHG$19.50B$5.37B$3.77B+1.23%+20.18%
PKI$4.57B$1.40B$631.71M+15.91%+6.40%
CRL$3.78B$864.40M$436.39M+15.42%+15.63%
ICLR$7.66B$1.30B$464.33M+34.54%+2.05%
View Top Diagnostic & Research Stocks

Quest Diagnostics Earnings & Revenue FAQ

What were DGX's earnings last quarter?

On Invalid Date, Quest Diagnostics (NYSE: DGX) reported Q3 2022 earnings per share (EPS) of $2.20, up 46.47% year over year. Total Quest Diagnostics earnings for the quarter were $256.00 million. In the same quarter last year, Quest Diagnostics's earnings per share (EPS) was $4.11.

If you're new to stock investing, here's how to buy Quest Diagnostics stock.

What was DGX's earnings growth in the past year?

As of Q1 2023, Quest Diagnostics's earnings has grown -38.77% year over year. This is 41.31 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 2.54%. Quest Diagnostics's earnings in the past year totalled $1.24 billion.

What was DGX's revenue last quarter?

On Invalid Date, Quest Diagnostics (NYSE: DGX) reported Q3 2022 revenue of $2.49 billion up 10.38% year over year. In the same quarter last year, Quest Diagnostics's revenue was $2.77 billion.

What was DGX's revenue growth in the past year?

As of Q1 2023, Quest Diagnostics's revenue has grown -6.81% year over year. This is 19.82 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 13.01%. Quest Diagnostics's revenue in the past year totalled $10.29 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.